Redx Pharma Limited

Redx is a clinical-stage biotechnology company focused on the discovery and development of small molecule, targeted medicines for the treatment of fibrotic disease, cancer, and cancer-associated fibrosis. The company has experience in drug discovery and has delivered multiple molecules to clinical stage development.
  • Zelasudil (RXC007, ROCK2 selective)
  • RXC008 (GI-targeted pan-ROCK inhibitor)
  • Zamaporvint (RXC004, Porcupine Inhibitor)
  • Oncology and fibrosis research programmes
Size
Medium
Phone
N/A
Website
redxpharma.com
Email
N/A
Locations
Alderley Park, Block 33 Mereside, SK10 4TG
01625469900
Digital Popularity
Popularity over time
Social Media
Company Details
Redx Pharma Limited is operated by Redx Pharma Limited and is a Active company incorporated on 7 September 2010 with the registered office located in Macclesfield, Cheshire. Redx Pharma Limited was registered 15 years ago.
Status
Active
Size
Small
Directors
10
Age
15 years old
Employees
74
Turnover
£13.52M
Total Assets
£28.36M
Cash in Bank
£18.56M
Total Liabilities
-£21.08M
Dr Bernhard Jurgen Kirschbaum
Director • German • Lives in Germany • Born in May 1958
Natalie Berner
Director • Co Director • American • Lives in United States • Born in Dec 1990
Lisa Mary Whewell Anson
Director • Pharmaceuticals Executive • British • Lives in England • Born in Apr 1968
Dr Robert Andrew Donald Scott
Director • Physician • American • Lives in United States • Born in Jul 1953
Jeremy Charles Green
Director • Portfolio Manager • British • Lives in France • Born in Jun 1973
Peter Eric Presland
Director • Chartered Accountant • British • Lives in England • Born in Apr 1950
More information on Redx Pharma Limited
Teams
All
65
Research
41
Management
28
Marketing
2
Customer Service
1
Other
10
Inder Bhamra
Vice President Drug Discovery • Joined Nov 2022
Nicolas Guisot
Vice President, Drug Discovery • Joined Nov 2022
Helen McKeever
Vice President Head Of Nonclinical Development • Joined Sep 2024
Cliff Jones
Senior Vice President Chemistry, DMPK & IP • Joined Nov 2022
Lisa LM Anson
Chief Executive Officer • Joined Jun 2018
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
Helen Aylott
Associate Principal Scientist • Joined Jan 2024
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
Helen Aylott
Associate Principal Scientist • Joined Jan 2024
Paula Jackson
Associate Principal Scientist • Joined Jan 2023
Nicola Hamilton
Associate Principal Scientist • Joined Dec 2021
Christopher Piekarski
Associate Principal Scientist • Joined Dec 2021
Elaine Kilgour
Head Of Translational Science • Joined Jan 2023
Jonathan Cheung
Associate Scientist
Lisa LM Anson
Chief Executive Officer • Joined Jun 2018
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
James Mead
Chief Operating Officer • Joined May 2021
David Marshall
Procurement Lead • Joined Aug 2022
Hayley Thomas
HR Manager • Joined Mar 2015
Caroline Phillips
Head Of Oncology • Joined Sep 2018
Helen Timmis
Senior Medical Director • Joined Feb 2022
Caitlin Pearson
Head Of Communications • Joined Apr 2022
Caroline Phillips
Head Of Oncology • Joined Sep 2018
Alexander Haworth
IT Support Lead • Joined Mar 2021
Inder Bhamra
Vice President Drug Discovery • Joined Nov 2022
Nicolas Guisot
Vice President, Drug Discovery • Joined Nov 2022
Helen McKeever
Vice President Head Of Nonclinical Development • Joined Sep 2024
Cliff Jones
Senior Vice President Chemistry, DMPK & IP • Joined Nov 2022
James McDonagh
Principal ChemAI Scientist • Joined Jul 2024
Simon Woodcock
VP, Oncology • Joined Nov 2022
Caroline Phillips
SVP Biology • Joined Nov 2022
Cinzia Bordoni
Senior Scientist In Medicinal Chemistry And Expert In Computational Chemistry • Joined Jul 2022
Joanne Kelley
Business Development Redx Pharma • Joined Sep 2019
Alex H
Strategic Finance / Corp Dev • Joined Sep 2024
View 65 members